Amrit Multispeciality Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-07-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.30 Cr
as on 17-07-2024
- Revenue 19.00%
(FY 2022)
- Profit 11.93%
(FY 2022)
- Ebitda 2.62%
(FY 2022)
- Net Worth 18.05%
(FY 2022)
- Total Assets -4.21%
(FY 2022)
About Amrit Multispeciality Hospitals
The Company is engaged in the Real Estate Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹3.30 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Arvind Garg, Ankur Aggarwal, Sunil Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110DL2012PTC236367
- Company No.
236367
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Amrit Multispeciality Hospitals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Garg  | Additional Director | 16-Apr-2014 | Current |
| Ankur Aggarwal | Additional Director | 20-Feb-2013 | Current |
| Sunil Kumar | Director | 23-May-2012 | Current |
| Sarthak Jain | Director | 23-May-2012 | Current |
Financial Performance and Corporate Structure Insights of Amrit Multispeciality Hospitals.
Amrit Multispeciality Hospitals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19% increase. The company also saw a substantial improvement in profitability, with a 11.93% increase in profit. The company's net worth Soared by an impressive increase of 18.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amrit Multispeciality Hospitals?
In 2022, Amrit Multispeciality Hospitals had a promoter holding of 76.78% and a public holding of 23.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 21 May 2013 | ₹3.30 Cr | Satisfied |
How Many Employees Work at Amrit Multispeciality Hospitals?
Unlock and access historical data on people associated with Amrit Multispeciality Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amrit Multispeciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amrit Multispeciality Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
